A novel humanized antibody targeting CD39 that enhances anti-tumor immunity and the efficacy of cancer immunotherapy.

被引：0

作者：

Ban, Haruka ^{[1
]}

Obonai, Toshifumi ^{[1
]}

Mishima, Yuji ^{[1
]}

Matsumoto, Noriko ^{[1
]}

Mie, Motoya ^{[1
]}

Nakamura, Norihiro ^{[1
]}

机构：

[1] BrightPath Biotherapeut Co Ltd, Kawasaki, Kanagawa, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14508

引用

页数：1

共 50 条

[31] CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy [J].

Li, Bingyu ;

Xu, Lijun ;

Pi, Chenyu ;

Yin, Yanxin ;

Xie, Kun ;

Tao, Fei ;

Li, Renhao ;

Gu, Hua ;

Fang, Jianmin .

ONCOIMMUNOLOGY, 2018, 7 (01)

[32] Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model [J].

Mashhouri, Siavash ;

Rahmati, Amirhossein ;

Azimi, Ako ;

Fava, Roy A. ;

Ismail, Ismail Hassan ;

Walker, John ;

Elahi, Shokrollah .

CELLULAR ONCOLOGY, 2024, 47 (05) :1735-1756

[33] Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses [J].

Shevchenko, Ivan ;

Mathes, Andreas ;

Groth, Christopher ;

Karakhanova, Svetlana ;

Mueller, Verena ;

Utikal, Jochen ;

Werner, Jens ;

Bazhin, Alexandr V. ;

Umansky, Viktor .

ONCOIMMUNOLOGY, 2020, 9 (01)

[34] PMN and anti-tumor immunity-The case of bladder cancer immunotherapy [J].

Brincks, Erik L. ;

Risk, Michael C. ;

Griffith, Thomas S. .

SEMINARS IN CANCER BIOLOGY, 2013, 23 (03) :183-189

[35] Modulation of Nr2f2 reprograms tumor blood vessels to enhance anti-tumor immunity and immunotherapy. [J].

Zhu, Yu ;

Lazarus, Nicole ;

Brulois, Kevin ;

Salazar, Nicole ;

Dinh, Theresa ;

Pan, Junliang ;

Butcher, Eugene .

CANCER RESEARCH, 2021, 81 (13)

[36] Fuzi Enhances Anti-Tumor Efficacy of Radiotherapy on Lung Cancer [J].

Zhang, Qi ;

Chen, Xue ;

Luo, Youjun ;

Ren, Huaping ;

Qiao, Tiankui .

JOURNAL OF CANCER, 2017, 8 (19) :3945-3951

[37] A humanized anti-cd40 antibody with anti-tumor pharmacological activity and cynomolgus monkey safety [J].

Li, Zhenyu ;

Zhao, Lili ;

Zhang, Guimin ;

Li, Bin ;

Liu, Zhong ;

Li, Guangyan ;

Zhu, Zhongsong .

CANCER RESEARCH, 2023, 83 (07)

[38] Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer [J].

Mo, Lijun ;

Chen, Qianmei ;

Zhang, Xinji ;

Shi, Xiaojun ;

Wei, Lili ;

Zheng, Dianpeng ;

Li, Hongwei ;

Gao, Jimin ;

Li, Jinlong ;

Hu, Zhiming .

VACCINE, 2017, 35 (43) :5932-5938

[39] CD73 targeting therapy enhances the anti-tumor effect of radiation therapy in rectal cancer [J].

Tsukui, Hidenori ;

Horie, Hisanaga ;

Saito, Akira ;

Koinuma, Koji ;

Ohsawa, Hideyuki ;

Yamaguchi, Hironori ;

Sakuma, Yasunaru ;

Hosoya, Yoshinori ;

Yoshimura, Kotaro ;

Lefor, Alan ;

Sata, Naohiro ;

Kitayama, Joji .

CANCER RESEARCH, 2020, 80 (16)

[40] Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma [J].

Jing Liao ;

Dan-Ni Zeng ;

Jin-Zhu Li ;

Qiao-Min Hua ;

Zhiyu Xiao ;

Chuanchao He ;

Kai Mao ;

Ling-Yan Zhu ;

Yifan Chu ;

Wei-Ping Wen ;

Limin Zheng ;

Yan Wu .

Hepatology International, 2020, 14 :80-95

← 1 2 3 4 5 →